The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
ESMO - European Society for Medical Oncology
Loading...
#ESMOGynae26: #LiquidBiopsy, such as circulating tumour DNA to monitor tumour-derived #Biomarkers, is a minimally invasive tool with the potential to guide therapy of gynaecological cancers, as discussed by Kosei Hasegawa. #ESMODailyReporter https://ow.ly/Hpq550ZeysZ
#ESMOGynae26: Intensification #Immunotherapy could provide an efficacy benefit in patients with locally advanced #CervicalCancer, according to data from phase 2 #ClinicalTrials of nivolumab plus ipilimumab and dostarlimab.
#ESMODailyReporter: https://ow.ly/aw1H50ZefZp
#ESMOGynae26: Data from two #ClinicalTrials provide long-term #EfficacyAndSafety evidence for the #CheckpointInhibitor dostarlimab, suggesting that immunotherapy may be used with curative intent in #EndometrialCancer. #ESMODailyReporter➡️ https://ow.ly/Mqq150ZefWk
🙌 #ESMOGynae26: Welcome to the global meeting place for gynaecological cancer specialists. Discover the latest science, share real-world experience, and collaborate with international experts to shape the future of patient care.
🔗 https://ow.ly/Z3WF50Zcfg1
#esmomeetings
👏 Congratulations to the #ESMOMeritAward recipients at #ESMOGynae26.
These young researchers were recognised for the scientific merit of their abstracts.
🔗 https://ow.ly/1PGm50Zc9gz
#ESMOGynae26: Early-phase #ClinicalTrials in #CervicalCancer show efficacy for a nectin-4-targeting ADC as monotherapy (recurrent/metastatic disease) or with toripalimab (metastatic disease), as discussed by Camilla Nero in the #ESMODailyReporter ➡️ https://ow.ly/NlT650ZcI2w
#ESMOGynae26: ADCs are transforming the treatment of advanced #OvarianCancer, #CervicalCancer and #EndometrialCancer, but what is their optimal sequencing alongside current therapies? Read Paolo Tarantino, MD's editorial in the #ESMODailyReporter 🔗 https://ow.ly/LeB450ZcASZ
Are you interested in #TumorAgnostic therapy?
Join the #YO4YO session with Benedikt Westphalen, Ana Tecic Vuger and Myrto Moutafi to learn more about navigating #MolecularTargets across histologies.
#ESMOYOC
📅 7 July 2026 15:00-16:00 CEST
🔗 https://ow.ly/qTWk50ZbHZk
📣 On-demand sessions from #ESMOTATAsia26 are now live on OncologyPRO.
📌 Available where speaker permission has been granted
👉 Watch now: https://ow.ly/c00r50ZaYEt
#ESMOMeetings #TargetedTherapies #Oncology
👉 In this #ESMODeepDive, we turn mHSPC complexity into practical decisions—treatment optimisation, sequencing & emerging data. Plus live Q&A 💬
🔗 ESMO member: secure your seat: https://ow.ly/2JRm50ZbJ5R
#ESMOWebinar #ESMOOnAir
